Related Experiment Videos
Bacterial resistance to the cyclic glycopeptides
1Research Service, Dept of Veterans Affairs Medical Center, Cleveland.
Trends in Microbiology
|October 1, 1994
Summary
Cyclic-glycopeptide antibiotic resistance is emerging in Gram-positive bacteria. Enterococci develop resistance by altering cell-wall precursors, reducing antibiotic effectiveness.
Area of Science:
- Microbiology
- Antibiotic Resistance
- Molecular Biology
Background:
- Cyclic-glycopeptide antibiotics (vancomycin, teicoplanin) have historically shown uniform activity against Gram-positive pathogens.
- Emergence of resistance threatens the efficacy of these critical antibiotics.
Purpose of the Study:
- To investigate the mechanisms of emerging antibiotic resistance in pathogenic Gram-positive bacteria.
- To understand how enterococci and staphylococci are developing resistance to cyclic-glycopeptide antibiotics.
Main Methods:
- Analysis of resistance mechanisms in enterococci and staphylococci.
- Investigation of genetic and mutational pathways leading to resistance.
Main Results:
- Resistance is emerging in enterococci and staphylococci.
- Enterococcal resistance involves the synthesis of altered cell-wall precursors.
- Staphylococcal resistance is associated with specific mutations.
Conclusions:
- The emergence of resistance necessitates further research into alternative treatments.
- Understanding resistance mechanisms is crucial for developing new antimicrobial strategies.